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ABSTRACT Clinical formulations of the antiarthritic drug aurothiomalate sometimes contain
phenylmercury(ll) compounds as antimicrobial preservative agents and, in the presence of para-
chloromercuri-benzoate, aurothiomalate is a potent inhibitor of collagenase. By 1H NMR
spectroscopy, para-hydroxymercuribenzoate and para-hydroxymercuriphenylsulphonate were
shown to react with aurothiomalate by complexing only with the terminal thiomalate of
aurothiomalate oligomers, thereby converting them to ring complexes. The reaction was also
detected by UV spectroscopy. The arylmercury complexes produced no change in the bulk of the
thiomalate residues of aurothiomalate indicating considerable stability of the polymeric structure of
aurothiomalate in which each gold is bound to two thiolate residues. The potent inhibition of the
mercurial induced collagenase activity may be due either to aurothiomalate or to a complex formed
between the terminal thiomalate residues with the arylmercurial. The arylmercury complexes may
be unsuitable as antimicrobials in solutions of aurothiomalate because of complexation with the
terminal thiomalate residues.
INTRODUCTION
Aurothiomalate ("Myocrisin") is a widely used antiarthritic drug. It has never been
crystallized, but X-ray absorption fine structure analysis and wide angle X-ray scattering
measurements suggest that it contains hexameric rings and oligomeric chains, consistent with the
presence of about 10-15% excess of thiomalate over gold in most preparations [1,2] (Fig. 1). We
report here studies of the interaction of aurothiomalate with phenylmercury(ll) complexes by NMR
and UV spectroscopy. Interest in the interaction of aurothiomalate with arylmercury(ll) complexes
arises firstly from the observation that aurothiomalate is a potent inhibitor of the enzyme
collagenase (IC5o 3.5 nM [3]) in the presence of para-hydroxymercuribenzoate (BHgOH) which
activates the enzyme [3,4]. Aurothiomalate alone is only a weak inhibitor of collagenase when
isolated in its active form [3,5] and a weak activator of the latent enzyme [3]. Secondly, an
arylmercurial, phenylmercury(ll) nitrate, has been used as a bactericide in some formulations of
aurothiomalate. The presence of an arylmercurial which can bind thiolate groups in a preparation of
a drug which is itself a thiolate complex allows the possibility of complex chemical interactions. It is
clearly important to know the precise chemical composition of any preparation which is
administered to man.
Arylmercury(ll) complexes, particularly BHgOH, are widely used in biochemistry as thiol
reagents and the nature of their reactions with the free ligand, thiomalate, is of general interest in
biochemistry. In the present work, the chemical reactions between aurothiomalate and thiomalate
with arylmercury(ll) complexes were studied mainly using para-hydroxymercuriphenylsulphonate
(PSHgOH) as the prototype arylmercury(ll)complex. It is highly soluble in water and can be
buffered to neutral pH values without precipitation. By comparison, BHgOH is difficult to use
because it precipitates as the free acid at pH values below about 9 but it was used in unbuffered
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solutions to confirm the findings produced with PSHgOH. Phenylmercuric nitrate is sparingly
soluble in water (about 1 mM) and therefore BHgOH and PSHgOH were preferred for the NMR
work described here.
Although arylmercurials are widely used as thiol reagents, there is surprisingly little detailed
information on the nature of their reactions with thiols, particularly using modern techniques.
Spectrophotometric titrations of BHgOH with thiomalate show a gradual increase in absorption at
about 250 nm with increasing amounts of the mercurial with a sharp end-point consistent with a
single product of the type, BHgStm, although the corresponding titration with cysteine indicated
the possibility of more than one organomercurial reacting with the cysteine when BHgOH was in
excess [6]. Data obtained in the present study indicate more complex interactions between
arylmercuric complexes than previously detected.
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Figure 1. (A) Structure of thiomalate showing protons giving rise to the ABX H NMR spectrum.
(B) Oligomeric structure of aurothiomalate. Note that the chain is terminated by thiomalate residues
and that them must be one more thiomalate residue than gold atoms in the oligomer.
(C) Hexameric ring structure of aurothiomalate.
MATERIALS AND METHODS
Aurothiomalate, the kind gift of RhSne Poulenc (Dagenham), was an off-white solid with
approximate composition Au(tm)1.15. 0.3(glycerol). 2H20. Thiomalic acid and the sodium salts of
PSHgOH, and BHgOH were purchased from Sigma. Solutions of sodium thiomalate were
prepared by neutralization of thiomalic acid solutions with sodium hydroxide and, for NMR
spectroscopy, were then freeze-dried twice from D20. Reactions between aurothiomalate,
thiomalate and the mercury complexes were studied by NMR in D20 solutions. Reactions involving
BHgOH were carried out in unbuffered solutions with a final pH* (pH meter reading in D20) of about
9.2; attempts to lower the pH* resulted in precipitation. In addition, the reactions of aurothiomalate
and thiomalate with PSHgOH were carried out in 0.1 M phosphate buffer in D20, pH* 7.0. The final
pH* values ranged from 6.99 to 7.03.
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H NMR spectra were recorded on Varian VXR400 and JEOL GSX500 spectrometers at
400 and 500 MHz respectively, and 99Hg-{H} NMR spectra at 71.3 MHz on the Varian instrument.
For H NMR, 5 mm tubes were used and peaks referenced to sodium trimethylsilyl-d4-propanoate.
Typical pulse conditions were 5000 Hz spectral width, 32 K computer points, 3.3 s acquisition time,
45 pulses, 128 scans. For 199Hg-{1H} spectra, 10 mm tubes were used and typical pulse
conditions were 100 KHz spectral width, 32 K computer points, 0.16 s acquisition time, 90 pulses,
0.5 s pulse delay, and 8000 scans. Mercuric chloride (1 M) in ethanol was used as an external
standard.
UV spectra were obtained on a Hitachi spectrophotometer (model U-3210) with 1 cm cells
at room temperature. Aurothiomalate (100 to 300 IM) or thiomalate (10 to 50 IM) were mixed with
PSHgOH (50 IM) in 0.05 M phosphate buffer, pH 7.0. Absorbances at 240, 245, 250 and 260 nm
were recorded and the absorbances due to PSHgOH and aurothiomalate subtracted. Solutions of
aurothiomalate were allowed to stand for at least 2 hours before the addition of PSHgOH to avoid
absorbance changes which occur on dissolution [7].
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Figure 2. Aromatic (left) and aliphatic (right) regions of 500 MHz H NMR spectra of thiomalate and
PSHgOH alone, and at mol ratios of 0.5:1, 1:1, and 2:1.
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RESULTS
First we studied the reaction between thiomalate and BHgOH and PSHgOH by 1H NMR
spectroscopy. Thiomalate itself exhibits an ABX-type spectrum with the CHx proton downfield of
the peaks from the non-equivalent CH2 protons (Figs. 1,2) [8]. In this aliphatic region of the 1H
NMR spectrum, the addition of PSHgOH produced a marked downfield shift in all resonances,
being largest for the CHx resonance (Fig. 2, Table I).
This downfield shift is consistent with the deshielding of the protons of thiomalate on
complexation with the organomercurial to give PSHgStm, where PSHg is the para-mercuri-
phenylsulphonate group and Stm is the thiolate group in thiomalate. In the presence of excess
thiomalate, broad resonances were seen indicating equilibration between free thiomalate and
PSHgStm at an intermediate rate on the NMR time scale (Fig. 2). The downfield shifts were
greatest when the mercurial was in excess, suggesting the formation of an intermediate,
(PSHg)2Stm.
Clear evidence of interaction between the PSHgOH and thiomalate was also shown by
changes in the NMR spectra of the ortho and meta protons of the organomercurial. The two
doublets in this region, and their 199Hg satellites shifted progressively downfield (Fig. 2).
The resonances of aurothiomalate formed three poorly defined groups with chemical shifts
of approximately 2.68, 2.86 and 4.07 p.p.m and were considerably sharpened and shifted slightly
upfield by the reaction with PSHgOH (Fig. 3). Thus, there has been little change in the chemical
environment of the bulk of the thiomalate residues in aurothiomalate, the sharpening of the peaks
being possibly due to the removal of chain terminating thiomalate and therefore the absence of
line-broadening due to chemical exchange (Fig 1). Smaller peaks in the aliphatic region of the NMR
spectra indicate the formation of adducts of PSHgOH with some of the thiomalate ligands present
in aurothiomalate. In particular, the broad peak at 4.15 p.p.m, seen at a 5:1 mol ratio of
aurothiomalate to the organomercurial is consistent with the formation of a thiomalate mercurial
complex.
Clearer evidence for the reaction between PSHgOH and some of the thiomalate ligands in
aurothiomalate is shown by the changes in the resonances in the aromatic region of the NMR
spectra. At a 10:1 mol ratio of aurothiomalate to the mercury complex, the major resonances are
centered at 7.63 and 7.83 ppm, identical with the chemical shifts of products of the interaction
PSHgOH and thiomalate alone. Similar major resonances are seen in the 1:1 and 2:1 mixtures of
thiomalate and PSHgOH when the major product of the reaction should be the monothiolato
complex, PSHgStm (Fig. 3). At lower mol ratios of PSHgOH to aurothiomalate (5:1 and 2:1), there
is considerable broadening of the major aromatic resonances, attributable to exchange of PSHg+
between the different species, e.g. (PSHg)2Stm, PSHgStm and PSHgOH at an intermediate rate
on the NMR timescale. No such broadening was observed with thiomalate and excess PSHgOH
indicating that exchange of PSHg+ with free thiomalate is faster than with gold bound thiomalate.
Reaction between PSHgOH and some of the thiomalate residues of aurothiomalate was
also evident from the appearance of two doublets in the aromatic region corresponding to the
minor product of the reaction between the PSHgOH and thiomalate itself (Figs. 2 and 3). This
product was detectable in all mixtures of aurothiomalate and PSHgOH at mol ratios from 0.5:1 to 5:1
but absent from the 10:1 mixture. When present, the NMR resonances from this minor product
remained sharp with constant chemical shifts indicating that this species is not in rapid exchange
with the other arylmercurial complexes present.
Reactions between thiomalate and aurothiomalate with BHgOH followed a similar pattern to
those with PSHgOH although the reactions could not be studied at physiological pH values. The
major difference was that no species corresponding to (PSHg)2Stm was seen in solutions of
thiomalate and BHgOH. A minor product was also seen from the pairs of doublets in the aromatic
region.
Reaction of thiomalate ligands in aurothiomalate solutions with PSHgOH was confirmed by
ultraviolet spectroscopy. Increased absorbance in the range 240 to 260 nm resulted from the
addition of PSHgOH to both thiomalate and aurothiomalate, indicating the production of a S-bound
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thiomalate arylmercuric complex (Fig. 4). Comparison of the absorbance change with that
produced bythe reaction of PSHgOH with thiomalate alone indicated that about 10% of the
thiomalate in aurothiomalate reacted the arylmercuric complex. The accuracy of this procedure was
limited by the high background absorbance of aurothiomalate of about ten times the absorbance
due the arylmercuric thiomalate complex. Furthermore, the complexation of chain-terminating
thiomalate groups and consequent changes in the structure of aurothiomalate may alter the
absorbance of aurothiomalate.
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Figure 3. Aromatic (left) and aliphatic (right) regions of 500 MHz H NMR spectra of
aurothiomalate and PSHgOH alone, and at tool ratios of 0.5:1, 1"1, 2:1, 5:1 and 10:1. The
resonances labelled g arise from glycerol which is present in sodium aurothiomalate.
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Table I. Chemical shifts (parts per million) and coupling constants (Hz) of H NMR resonances of
aurothiomalate (Autm), thiomalate (tmSH) and complexes formed by the interaction between
thiomalate (tmSH) and PSHgOH.
Species Aliphatic resonances Aromatic resonances
Chemical Coupling Chemical Coupling
shift constant shift constant
CHA CHB CHx J JAX JBX CHA CHB JAB
tmSH 2.829 2.446 3.611 15.4 5.8 9.6
PSHgOH:tmSH 3.000 2.695 4.417 15.7 4.8 9.5
(2:1)
PSHgOH:tmSH 2.901 2.501 4.165 15.0 5.1 9.9
(1"1)
PSHgOH
Autm 2.85* 2.68* 4.07*
7.809 7.616 8.4
7.820 7.637 8.2
7.789 7.588 8.4
Approximate chemical shifts
0.2
0.15
0.1
0.05
0
240 250 260
WAVE,_ENGTH (nm)
B 100 pM
200 pM
300/M
Figure 4. UV difference spectra of aurothiomalate (100 to 300 M) in the presence of PSHgOH
(50 IM)in phosphate buffer, pH 7.0. The recorded absorbances are those of mixtures of
aurothiomalate and PSHgOH from which the absorbances of unreacted aurothiomalate and
PSHgOH have been subtracted.
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The reaction between PSHgOH and thiomalate was also studied by 99Hg NMR. The
chemical shifts of PSHgOH was -1365 p.p.m, increasing progressively to -1240 and -913.7 ppm at
ratios of thiomalate to PSHgOH of O.5:1 and 1:1, respectively. No further change in the resonance
of 199Hg occurred on the addition of a further equivalent of thiomalate.
The nature of the PSHgOH complexes with thiomalate was also investigated by matrix
assisted laser desorption mass spectrometry. A solution containing PSHgOH and thiomalate in a
1:1 mol ratio, however, did not give rise to any observable peaks.
DISCUSSION
Arylmercury complexes are useful thiol reagents in biochemistry, but a simple 1:1 complex
is not the only product formed. A bisarylmercury(ll) complex of the type (PSHg)2Stm may be
formed in the presence of excess arylmercurial mercurial complex and a minor product, possibly
PSHg(Stm)2, is formed in the presence of excess thiomalate. The latter type of complex in which
the coordination number of mercury is 3 has been reported with methylmercury although the
stability constant is predicted to be low [9]. It is probable that the stabilities of similar complexes of
arylmercury complexes are also low.
As discussed above, aurothiomalate forms chains which are terminated by the excess
thiomalate present and the interaction of aurothiomalate and PSHgOH is consistent with the
reaction of only this excess thiomalate with the organomercurial. The corollary, however, is that the
chains must lengthen if the gold in aurothiomalate remains bound to two sulphur atoms or that
cyclic structures are formed (Fig. 1). Despite this possible lengthening of the aurothiomalate
polymer, the NMR resonances of the thiomalate resonances actually sharpened on the addition of
the arylmercurials. Similar sharpening of the broad thiomalate resonances in aurothiomalate was
noted when small amounts of the thiol reagent, 5,5’-dithiobis-(2-nitrobenzoic acid) (EIIman’s
reagent) were added to aurothiomalate [10]. Possibly, the removal of chain terminating thiolates
leads to the production of cyclic structures with sharper NMR resonances due to the removal of
exchange broadening reactions (Figs. 1 and 2).
The conclusion that the structure of aurothiomalate is not greatly altered by the
arylmercurials is consistent with previous data demonstrating that the reactivity of aurothiomalate
towards cysteine is also not altered by the presence of aryl mercurials. The latter was indicated by
the data of Danpure and Fyfe [11] who found that the aryl mercurials do not inhibit the interaction
between aurothiomalate and cysteine although the interaction between cysteine and the aryl
mercurials is blocked. The complex formed between PSHgOH and thiomalate is very stable (log
association constant 17.3) [12], and. the lack of interaction of PSHgOH with the bulk of the
thiomalate residues in aurothiomalate is consistent with the very considerable stability of the Au
thiolate bond and the polymeric structure of aurothiomalate.
There has been little published work on the NMR spectroscopy of the aryl mercurial
complexes. It was reported that the chemical shifts of the ortho protons of various PhHgX
compounds (where Ph phenyl)in dimethylsulphoxide are independent of the nature of the X
group whereas the magnitudes of the coupling constants, j(1Hortho -199Hg), vary with the
substituents [13]. A similar result was found in the present study. The resonances of both the
ortho and meta protons of the arylmercurials were shifted only slightly downfield by the reactions of
the arylmercurials with thiomalate (Fig 2).
Apart from giving basic information on the chemistry of aurothiomalate, this work was also
designed to give information on questions about the interaction between aurothiomalate and
arylmercury complexes. The first concerned the inhibitory action of aurothiomalate on collagenase
activated by BHgOH. In this system, the inhibitory effect of aurothiomalate was shown at
concentrations far below the concentrations of the arylmercurial [3]. Such conditions could not be
reproduced in the present NMR spectroscopic studies but from the present studies where there
was an excess of the mercurial, it seems unlikely that the basic structure of aurothiomalate should
be altered. It is probable that BHgOH forms complexes only with the chain terminating thiomalate
residues and, if free BHgOH is available after its activation of collagenase, the total concentration of
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complexes of BHgOH with thiomalate should be about 10 to 15% of that of aurothiomalate. Thus,
solutions of BHgOH and excess aurothiomalate should contain a cyclised form of aurothiomalate
and a thiomalato complex with BHgOH. Although the concentration of the thiomalate-arylmercury
complex should be lower than that of aurothiomalate, it is not possible to predict which species is
inhibiting the collagenase.
The present studies also provide information about the nature of the general reaction
between arylmercurials and thiol compounds as well as their interaction with aurothiomalate.
Typically, the commercial ampoules have contained far higher concentrations of aurothiomalate
(about 50 mM) compared to about 30 IM phenylmercury(ll) nitrate as an antimicrobial agent. Under
these conditions, it is probable that the products formed would resemble those in the 10:1 mixture
of aurothiomalate: PSHgOH. i.e. the aurothiomalate should be very largely unaltered while the
lower amount of the phenylmercury(ll) nitrate should be completely converted to the thiolate
derivative of the aryl mercury compound. With this chemical change, the anti-microbial activity of
phenylmercury(ll) nitrate would appear very doubtful. Recently, aurothiomalate solutions have
been sterilized by filtration rather than by heating in the presence of phenylmercury(ll) nitrate. This
appears to be a useful change in view of the probable inactivity of the arylmercury complex in the
presence of aurothiomalate.
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